SRRK
SRRK
NASDAQ · Biotechnology

Scholar Rock Holding Corp

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$48.39
+1.94 (+4.18%)
As of May 9, 1:18 AM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 21 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +47.3% upside
Low Target $54.07
Average Target $71.29
High Target $91.55
Current Price $48.39
Current
$48.39
Target
$71.29
$54.07 $71.29 avg $91.55
Scenario Analysis
Bear Case
$54.07
11.7%
Low target
Base Case
$71.29
+47.3%
Avg target
Bull Case
$91.55
+89.2%
High target
Risk/Reward
7.6x
Highly favorable
Price in Context
52-Week High
$51.63
-6.3% from high
52-Week Low
$27.07
+78.8% from low
50-Day SMA
$45.16
+7.2% vs SMA
200-Day SMA
$36.91
+31.1% vs SMA
RSI (14)
59.5
Neutral
Target vs 52W High
$71.29
+38.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%